Advertisement
Screener

Aptevo Therapeutics Inc. (APVO) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

Aptevo Therapeutics Inc. Preferred Stock, Shares Authorized

Aptevo Therapeutics Inc. (APVO) had Preferred Stock, Shares Authorized of 15.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-14

  • 2026-06-30: Preferred Stock, Shares Authorized 15.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 15.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 15.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-3015.00M shares
10-Q · filed 2026-08-14
2026-03-3115.00M shares
10-Q · filed 2026-05-13
2025-12-3115.00M shares
10-Q · filed 2026-08-14
2025-09-3015.00M shares
10-Q · filed 2025-11-06
2025-06-3015.00M shares
10-Q · filed 2025-08-11
2025-03-3115.00M shares
10-Q · filed 2025-05-15
2024-12-3115.00M shares
10-K · filed 2026-03-26
2024-09-3015.00M shares
10-Q · filed 2024-11-07
2024-06-3015.00M shares
10-Q · filed 2024-08-08
2024-03-3115.00M shares
10-Q · filed 2024-05-08
2023-12-3115.00M shares
10-K · filed 2025-02-14
2023-09-3015.00M shares
10-Q · filed 2023-11-14
2023-06-3015.00M shares
10-Q · filed 2023-08-10
2023-03-3115.00M shares
10-Q · filed 2023-05-11
2022-12-3115.00M shares
10-K · filed 2024-03-05
2022-09-3015.00M shares
10-Q · filed 2022-11-10
2022-06-3015.00M shares
10-Q · filed 2022-08-11
2022-03-3115.00M shares
10-Q · filed 2022-05-12
2021-12-3115.00M shares
10-K · filed 2023-03-30
2021-09-3015.00M shares
10-Q · filed 2021-11-12
2021-06-3015.00M shares
10-Q · filed 2021-08-12
2021-03-3115.00M shares
10-Q · filed 2021-05-11
2020-12-3115.00M shares
10-K · filed 2022-03-24
2020-09-3015.00M shares
10-Q · filed 2020-11-10
2020-06-3015.00M shares
10-Q · filed 2020-08-14
2020-03-3115.00M shares
10-Q · filed 2020-05-13
2019-12-3115.00M shares
10-K · filed 2021-03-31
2019-09-3015.00M shares
10-Q · filed 2019-11-07
2019-06-3015.00M shares
10-Q · filed 2019-08-09
2019-03-3115.00M shares
10-Q · filed 2019-05-09
2018-12-3115.00M shares
10-K · filed 2020-03-25
2018-09-3015.00M shares
10-Q · filed 2018-11-14
2018-06-3015.00M shares
10-Q · filed 2018-08-09
2018-03-3115.00M shares
10-Q · filed 2018-05-10
2017-12-3115.00M shares
10-K · filed 2019-03-18
2017-09-3015.00M shares
10-Q · filed 2017-11-13
2017-06-3015.00M shares
10-Q · filed 2017-08-10
2017-03-3115.00M shares
10-Q · filed 2017-05-12
2016-12-3115.00M shares
10-K · filed 2018-03-13
2016-09-3015.00M shares
10-Q · filed 2016-11-14
2015-12-3115.00M shares
10-K · filed 2017-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Onconetix, Inc. (ONCO)United States$0.004B
Sunshine Biopharma Inc. (SBFM)$0.003B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B